文献速递细菌感染、耐药与抗菌药物医院感染防控新发突发、热带与寄生虫病

注射吸毒相关感染存在大量漏记录、漏诊断或漏治疗机会:基于住院与急诊的人群队列研究

Many Opportunities to Record, Diagnose, or Treat Injection Drug-related Infections Are Missed: A Population-based Cohort Study of Inpatient and Emergency Department Settings.
PubMed 文献 · Clin Infect Dis · 2019-01-01

该回顾性队列研究利用加州、佛罗里达州和纽约州住院与急诊数据,识别血流感染或脓毒症、心内膜炎、骨髓炎或化脓性关节炎、皮肤软组织感染患者,比较感染诊断时记录与未记录吸毒但6个月内记录的病例。纳入未记录吸毒的感染后,年度注射吸毒相关感染数增加105%至218%,提示现有监测可能漏报超过一半病例。

要点

  • 纳入感染前后6个月内记录的吸毒信息后,注射吸毒相关感染年计数增加105%–218%。
  • 急诊诊断、医院治疗吸毒经验水平、年龄<18岁及Medicare主要支付方与吸毒未记录相关。
  • 现有监测可能漏报超过一半的注射吸毒相关感染,存在大量记录、诊断或治疗机会。

核心结论

  • 现有监测估算可能漏报超过一半的注射吸毒相关感染。
  • 患者因注射吸毒相关感染就诊时,存在大量记录、诊断或治疗潜在药物滥用的机会被错过。

研究设计与样本

  • 回顾性队列研究,使用加州、佛罗里达州和纽约州医疗成本与利用项目(HCUP)的住院和急诊就诊数据。
  • 识别所有诊断为血流感染或脓毒症、心内膜炎、骨髓炎或化脓性关节炎、皮肤或软组织感染的患者。

主要发现

  • 注射吸毒相关感染数量呈上升趋势。
  • 纳入吸毒未记录的感染后,年度注射吸毒相关感染数增加105%至218%。
  • 吸毒未记录的相关因素包括急诊诊断、医院治疗吸毒经验水平、年龄<18岁及Medicare为主要支付方。

关键数值与推荐

  • 注射吸毒相关感染定义为感染诊断时记录吸毒,或感染诊断时未记录但感染诊断前后6个月内记录吸毒。
  • 年度注射吸毒相关感染数在纳入未记录吸毒的感染后增加105%至218%。

临床怎么用

  • 临床医生在诊治注射吸毒相关感染时,应主动询问并记录吸毒史,尤其在急诊、低经验医院、青少年及Medicare患者中。
  • 对注射吸毒相关感染患者应评估并治疗潜在药物滥用,减少漏诊漏治。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Injection drug use (IDU) and IDU-related infections have increased dramatically. However, the incidence of IDU-related infections may be underreported because drug use is not recorded in diagnostic records where associated infections are identified. Our goal was to estimate a more accurate incidence of IDU-related infections by including IDU-related infections not recorded at the time infections are diagnosed. METHODS: We performed a retrospective cohort study using inpatient and emergency department visits from the Healthcare Cost and Utilization Project for California, Florida, and New York. We identified all patients diagnosed with bacteremia or sepsis, endocarditis, osteomyelitis or septic arthritis, and skin or soft tissue infection. We estimated the incidence of IDU-related infections by identifying cases where drug use was recorded at the time of an infection and cases where drug use was not recorded at the time of infection but within 6 months before or after the infection diagnosis. We also analyzed factors associated with unrecorded IDU. RESULTS: There has been an increasing trend in the number of IDU-related infections. The annual number of IDU-related infections increased between 105% and 218% after incorporating infections in which drug use was unrecorded. Factors associated with drug use being unrecorded included emergency department diagnosis, the level of hospital experience treating drug use, age <18 years, and having Medicare as the primary payer. CONCLUSIONS: More than half of all IDU-related infections may be unrecorded in existing surveillance estimates. There may be many missed opportunities to record, diagnose, or treat underlying drug abuse among patients presenting with IDU-related infections.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Miller AC, Polgreen PM. Many Opportunities to Record, Diagnose, or Treat Injection Drug-related Infections Are Missed: A Population-based Cohort Study of Inpatient and Emergency Department Settings. Clin Infect Dis. 2019. PMID: 30215683. doi:10.1093/cid/ciy632

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。